The continued
prosperity of a biopharma company is dependent on its ability to keep churning
out breakthrough new drugs and turning them into commercial successes backed by
a growing body of clinical evidence. Which shops are doing best on those terms?
In its latest
two indices, IDEA Pharma has ranked AstraZeneca at the top of the pharma invention
scale—awarding it "best pipeline" honors—and crowned Roche king in
the land of innovation.
AstraZeneca
previously sank to 12th place on the innovation scale but rose to 6th this
time, and it remained at the top of the invention scale for the second straight
year. How did the British drugmaker make it in 2019?